Sort
38,696 grants matching “als”
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,424,537Rachel R. Caspi · National Eye Institute · ZIA · FY2014 · EY
Genetic Analysis of T-cell Differentiation
$2,424,498Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Synthetic DNA-launched and adjuvanted Env immunogens for HIV
$2,424,072David B. Weiner · Wistar Institute · U19 · FY2025 · AI
Cell Signaling of Host Defense
$2,423,893Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Modeling Neurodegenerative Disease Manifestations in Human Enteric Neurons
$2,420,000Faranak Fattahi · University Of California, San Francisco · DP2 · FY2019 · NS
Cytokine Signaling, Immunoregulation and Autoimmune and Immunodeficiency Diseases
$2,416,945John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Gaalee'ya STEM Project
$2,415,720University Of Alaska Fairbanks Campus · · FY2008 · EDU
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$2,415,605Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling
$2,414,999Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2016 · HG
Phase 1 safety trial for CT1812, a novel small molecule therapeutic targeting a synaptic receptor for Abeta oligomers
$2,410,669Susan M Catalano · Cognition Therapeutics, Inc. · RF1 · FY2016 · AG
Phase 1b first-in-patient safety trial for CT1812, a novel Alzheimerâs synaptic protection therapeutic
$2,410,669Susan M Catalano · Cognition Therapeutics, Inc. · RF1 · FY2016 · AG
Pathophysiologic Consequences of Survival Signaling in Neuroblastoma
$2,409,315Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Genetic Basis Of Cortical Malfunction In Schizophrenia
$2,409,110Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2012 · MH
Accelerating drug development and repurposing using systematic genetic interactio
$2,407,500Michael C Bassik · Stanford University · DP2 · FY2014 · HD
Neuroimaging of Alcohol Addiction
$2,404,834Abdolreza Momenan · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA
Identification and characterization of the CD31-ApoE-mCRP pathway for Alzheimer's disease in humans.
$2,404,559Wei Qiao Qiu · Boston University Medical Campus · RF1 · FY2023 · AG
Role of G protein-coupled receptors in regulating glucose and energy homeostasis
$2,404,029Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Comprehensive Sickle Cell Center Program: Basic & Translational Research Program
$2,402,830Marie J. Stuart · Thomas Jefferson University · U54 · FY2008 · HL
Axonal transport of endolysosomal organelles and presynaptic cargos for the maintenance of axon cellular homeostasis and presynaptic function
$2,397,505Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment
$2,396,241Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2023 · DC
Functional Studies of "Deafness Genes" Essential for Hearing
$2,396,241Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2023 · DC
Regulation of axonal degeneration by the DLK kinase
$2,393,212Aaron Diantonio · Washington University · R37 · FY2020 · NS
Augmenting AXL and MERTK function to restrain cognitive decline and improve health span in mouse models of Alzheimer's Disease
$2,392,160Carla Rothlin · Yale University · RF1 · FY2023 · AG
Screening for a Drug for Sickle Cell Disease
$2,390,075William Eaton · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Genetic Analysis of T-cell Differentiation
$2,388,750Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA